
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MC1-R CRISPR/Cas9 KO Plasmid (m) | sc-421583 | 20 µg | $397.00 |
Mc1r encodes the melanocortin 1 receptor (MC1-R), a G protein–coupled receptor expressed prominently in melanocytes where it regulates pigmentation by coupling to Gs and stimulating cAMP/PKA signaling. MC1-R activation influences the balance of eumelanin versus pheomelanin synthesis through downstream effectors including CREB and melanogenic enzymes, integrating hormonal cues such as α-MSH and antagonism by agouti signaling protein. In mouse models, altered Mc1r activity modulates coat color phenotypes and intersects with pathways controlling oxidative stress responses and UV-induced damage handling in pigment cells. Because melanocortin signaling interfaces with MAPK and transcriptional programs governing melanocyte differentiation, Mc1r perturbation is useful for studying pigment cell biology, inflammation-related signaling crosstalk, and genotype-to-phenotype mapping in dermatologic research contexts.
MC1-R CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Mc1r gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Mc1r together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Mc1r open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MC1-R protein expression.
This CRISPR knockout system enables efficient generation of Mc1r-deficient cell models for investigation of MC1-R signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.